Key Insights

Highlights

Treatment Research

2 treatments under study, led by Hccrecurrencediagnosticscore

Research Leaders

5 sponsors active, led by Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Not Yet Recruiting1
Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07600515Not Yet Recruiting

Evaluation of Persistent Infection by Oncogenic Human Papillomavirus (HPV) in Patients Treated for Cervical Carcinoma and Its Relation to Prognostic Factors

NCT05866783RecruitingPrimary

Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma

Showing all 2 trials

Research Network

Common Treatments

  • Hccrecurrencediagnosticscore1
  • Hccrecurrenceprognosticscore1

Active Sponsors

  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain1
  • Instituto do Cancer do Estado de São Paulo1
  • Universitaire Ziekenhuizen KU Leuven1
  • University Hospital, Antwerp1
  • University Hospital, Ghent1

Related Conditions

  • Locally Advanced Cervical Cancer1
  • Liver Transplantation1
  • Hepatocellular Carcinoma1
  • Diagnostic Biomarker1

Activity Timeline